ATC code A05 Bile and liver therapy is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products. Subgroup A05 is part of the anatomical group A Alimentary tract and metabolism.[1]

ATC codes
A Alimentary tract and metabolism
A01 Stomatological preparations
A02 Drugs for acid related disorders
A03 Drugs for functional gastrointestinal disorders
A04 Antiemetics and antinauseants
A05 Bile and liver therapy
A06 Drugs for constipation
A07 Antidiarrheals, intestinal anti-inflammatory/anti-infective agents
A08 Antiobesity preparations, excluding diet products
A09 Digestives, including enzymes
A10 Drugs used in diabetes
A11 Vitamins
A12 Mineral supplements
A13 Tonics
A14 Anabolic agents for systemic use
A15 Appetite stimulants
A16 Other alimentary tract and metabolism products

Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QA05.[2] ATCvet codes without corresponding human ATC codes are cited with the leading Q in the following list.

National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.

A05A Bile therapyEdit

A05AA Bile acids and derivativesEdit

A05AA01 Chenodeoxycholic acid
A05AA02 Ursodeoxycholic acid
A05AA03 Cholic acid
A05AA04 Obeticholic acid

A05AB Preparations for biliary tract therapyEdit

A05AB01 Nicotinyl methylamide

A05AX Other drugs for bile therapyEdit

A05AX01 Piprozolin
A05AX02 Hymecromone
A05AX03 Cyclobutyrol
QA05AX90 Menbutone

A05B Liver therapy, lipotropicsEdit

A05BA Liver therapyEdit

A05BA01 Arginine glutamate
A05BA03 Silymarin
A05BA04 Citiolone
A05BA05 Epomediol
A05BA06 Ornithine oxoglutarate
A05BA07 Tidiacic arginine
A05BA08 Glycyrrhizic acid (glycyrrhizin)
QA05BA90 Methionine

A05C Drugs for bile therapy and lipotropics in combinationEdit

Empty group

ReferencesEdit

  1. ^ "ATC/DDD Index 2020: code A05". WHO Collaborating Centre for Drug Statistics Methodology.
  2. ^ "ATCvet Index 2020: code QA05". WHO Collaborating Centre for Drug Statistics Methodology.